Innovative strategies monitor volume status in heart failure

Heart failure is a common disease with high morbidity and mortality. Based on disease-specific estimates of prevalence and incidence rates of heart failure, it is estimated that the prevalence of heart failure in India due to coronary heart disease, hypertension, obesity, diabetes, and rheumatic heart disease range from 1.3 million to 4.6 million, with an annual incidence of 491,600 to 1.8 million.

More precise, reliable estimates are lacking because of the absence of a national surveillance program, according to the Center for Chronic Disease Control in India. Nevertheless, researchers and the medical community recognize that the incidence and prevalence of heart failure in India are on the rise. In Western countries, heart failure is thought of as an elderly persons’ disease, but in India, it can affect younger people as well, according to a 2010 paper in the Indian Journal of Medical Research.


“…Biomarker monitoring is likely to remain the mainstay of monitoring volume status for our heart failure patients.”
-K. Sarat Chandra, MD, DM, cardiologist and a member of the mdCurrent-India Editorial Advisory Board, Punjagutta, Hyderabad, India


The routine measurement of biomarkers is currently utilized in various clinical settings; however, there is a limitation in using biomarkers in the assessment of clinical status of heart failure. In theory, continuous monitoring of fluid status may help to identify cases of ...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Cardiovascular, Cardiovascular Disease, Non-Communicable Disease, Primary Care and tagged , , , , , , . Volume: .

Post a Comment

You must be logged in to post a comment.